Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
---|
02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
02/24/2004 | US6696488 Administering protease inhibitor |
02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
02/24/2004 | US6696424 Cytofectin dimers and methods of use thereof |
02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
02/12/2004 | WO2004013089A1 Fluorinated urethane compounds and compositions containing the same |
02/12/2004 | US20040030188 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
02/12/2004 | US20040029967 Phenylethylamine derivatives and their use in the treatment of melanoma |
02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
02/12/2004 | CA2493985A1 Fluorinated urethane compounds and compositions containing the same |
02/11/2004 | EP1387831A1 Substituted arylketones |
02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
02/11/2004 | CN1474679A Novel coupler for use in oxidative hair dyeing |
02/11/2004 | CN1137878C Aryloxyaniline derivatives |
02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
02/04/2004 | EP0813525B9 Benzamidine derivatives their preparation and their use as anti-coagulants |
02/03/2004 | US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
02/03/2004 | US6686394 Potent antineoplastic activity without systemic toxicity or mutagenicity |
02/03/2004 | US6686350 Cell adhesion inhibitors |
01/29/2004 | WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
01/29/2004 | CA2493458A1 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
01/28/2004 | CN1471509A 9-substituted minocycline compounds |
01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
01/27/2004 | US6683200 N-substituted-n'-substituted urea derivative is used as a tumor necrosis factor-alpha production inhibitory agent and a therapeutical agent for autoimmune diseases |
01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
01/22/2004 | WO2004007459A2 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
01/22/2004 | WO2004007436A1 Method for the continuous production of tetra-substituted ureas |
01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
01/22/2004 | US20040014968 Such as 2-(3-chloro-phenyl)-3-cyclopentyl-N-thiazol-2-yl-propionamide which increases insulin secretion in treatment of type II diabetes |
01/22/2004 | US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides |
01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
01/22/2004 | DE10231085A1 Verfahren zur kontinuierlichen Herstellung von tetrasubstituierten Harnstoffen Process for the continuous preparation of tetrasubstituted ureas |
01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
01/22/2004 | CA2489408A1 Method for the continuous production of tetra-substituted ureas |
01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
01/21/2004 | CN1468848A Continuous process for producing MDI carbamidoformate |
01/15/2004 | US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
01/14/2004 | EP1380564A1 Binaphtol derivative and process for producing the same |
01/14/2004 | EP1380558A1 Process for production of dimers of aromatic monohydroxyl compounds |
01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
01/14/2004 | EP1212292B1 (-)-verbenone derivatives |
01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | WO2004002941A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | US20040006056 Substituted alkanoic acids |
01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
01/07/2004 | CN1465563A Novel benzoylurea compound and use thereof |
01/06/2004 | US6673966 For use in hair coloring formulations |
01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
01/02/2004 | EP1027339B1 Method and reagents for n-alkylating ureides |
01/01/2004 | US20040002491 Melatonergic receptors |
01/01/2004 | US20040002490 Melatonergic receptors |
01/01/2004 | US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
12/31/2003 | WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
12/31/2003 | CN1463965A Process for preparing 4,4'-dinitro diphenyl urea |
12/31/2003 | CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
12/30/2003 | US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide; |
12/30/2003 | US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group |
12/30/2003 | US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
12/30/2003 | CA2140927C Platelet aggregation inhibitors |
12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
12/25/2003 | US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents |
12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
12/24/2003 | DE10225635C1 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung N-Benzoylureido-cinnamic acid derivatives, processes for their preparation and their use |
12/24/2003 | CN1463266A Binaphthol derivative and method for producing same |
12/24/2003 | CN1463264A Method for producing aromatic compound dimer |